title: Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action.
authors.affiliation: The Mathilda & Terrence Kennedy Institute of Rheumatology, Hammersmith, London, UK.
authors.forename: M
authors.initials: M
authors.lastname: Feldmann
authors.forename: F
authors.initials: F
authors.lastname: Brennan
authors.forename: E
authors.initials: E
authors.lastname: Paleolog
authors.forename: P
authors.initials: P
authors.lastname: Taylor
authors.forename: R N
authors.initials: RN
authors.lastname: Maini
mesh_terms: D001172:Arthritis, Rheumatoid / Q000209:etiology / Q000276:immunology* / Q000628:therapy*; D016207:Cytokines / Q000097:blood; D003602:Cytotoxicity, Immunologic; D015536:Down-Regulation; D006801:Humans; D007167:Immunotherapy; D066298:In Vitro Techniques; D018836:Inflammation Mediators / Q000097:blood; D009389:Neovascularization, Pathologic; D009500:Neutralization Tests; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D016207:Cytokines; D018836:Inflammation Mediators; D014409:Tumor Necrosis Factor-alpha